Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Whole genome sequencing and prediction of antimicrobial susceptibilities in non-tuberculous mycobacteria

29 Nov 2022

Abstract excerpt

Non-tuberculous mycobacteria (NTM) are opportunistic pathogens commonly causing chronic, pulmonary disease which is notoriously hard to treat. Current treatment for NTM infections involves at least three active drugs (including one macrolide: clarithromycin or azithromycin) over 12 months or longer. At present there are limited phenotypic in vitro drug susceptibility testing options for NTM which are standardised...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Actinomycetales infections and treatment
Share to Mycobacterium research and diagnosis
Share to Tuberculosis Research and Epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36523832
DOI: 10.3389/fmicb.2022.1044515

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Whole genome sequencing and prediction of antimicrobial susceptibilities in non-tuberculous mycobacteriaPMID 36523832Read ↗

Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort studySemantic proximity Read ↗

Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.Semantic proximity Read ↗

Genomic Diagnostics for Drug-Resistant Mycobacterium tuberculosis: Computational Prediction of Antimicrobial ResistanceSemantic proximity Read ↗

Clinical use of whole genome sequencing for Mycobacterium tuberculosisSemantic proximity Read ↗

Evaluating the efficacy of whole genome sequencing in predicting susceptibility profiles for first-line antituberculosis drugs.Semantic proximity Read ↗

Whole Genome Sequencing of Mycobacterium tuberculosis Clinical Isolates From India Reveals Genetic Heterogeneity and Region-Specific Variations That Might Affect Drug SusceptibilitySemantic proximity Read ↗

Rapid drug resistance prediction in positive Mycobacterium tuberculosis clinical samples using an extensive targeted next-generation sequencing panel.Semantic proximity Read ↗

A data compendium associating the genomes of 12,289 Mycobacterium tuberculosis isolates with quantitative resistance phenotypes to 13 antibiotics.Semantic proximity Read ↗

Characterising the performance of an antibiotic resistance prediction tool, gnomonicus, using a diverse testset of 2,663 <i>Mycobacterium tuberculosis</i> samplesSemantic proximity Read ↗

Whole-Genome Sequencing to Predict Mycobacterium tuberculosis Drug Resistance: A Retrospective Observational Study in Eastern ChinaSemantic proximity Read ↗

Use of whole genome sequencing in surveillance of drug resistant tuberculosis.Semantic proximity Read ↗

Mycobacterium tuberculosis and whole genome sequencing: a practical guide and online tools available for the clinical microbiologistSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.